TuHURA Biosciences(HURA.US)

Last Updated 19:00:00 ET
longbridge loading

Leverage, Covenants and Royalty Drain: Why Tuhura Biosciences’ Parkview Credit Deal Heightens Liquidity and Dilution Risks

Tip Ranks·
US
HURA
-1.22%
US
XBI
+2.30%
US
FBT
+2.23%
Tip Ranks·
US
HURA
-1.22%
US
XBI
+2.30%
US
FBT
+2.23%

TuHURA Biosciences, Inc. 1Q 2026: Revenue $0 Net loss $(7.54M), EPS $(0.13) — 10-Q Summary

TradingView·
US
HURA
-1.22%
US
BBH
+0.77%
US
SBIO
+2.31%
TradingView·
US
HURA
-1.22%
US
BBH
+0.77%
US
SBIO
+2.31%

TuHURA Biosciences | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
HURA
-1.22%
Earnings Watch·
US
HURA
-1.22%

TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update | HURA Stock News

StockTitan·
US
HURA
-1.22%
US
FBT
+2.23%
US
PBE
+2.12%
StockTitan·
US
HURA
-1.22%
US
FBT
+2.23%
US
PBE
+2.12%

TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference | HURA Stock News

StockTitan·
US
HURA
-1.22%
StockTitan·
US
HURA
-1.22%

TuHURA Biosciences (HURA) Expected to Announce Earnings on Friday

Market Beat·
US
HURA
-1.22%
US
PBE
+2.12%
US
BBH
+0.77%
Market Beat·
US
HURA
-1.22%
US
PBE
+2.12%
US
BBH
+0.77%

07:30 ETHanchorBio Selects Bloomberg to Strengthen its Strategic Intelligence Across Drug Development and Global Biopharma

prnewswire·
US
HBIO
+0.50%
US
HURA
-1.22%
US
XBI
+2.30%
prnewswire·
US
HBIO
+0.50%
US
HURA
-1.22%
US
XBI
+2.30%

TuHURA Biosciences Secures $50 Million Credit Facility

Tip Ranks·
US
HURA
-1.22%
US
FBT
+2.23%
US
BBH
+0.77%
Tip Ranks·
US
HURA
-1.22%
US
FBT
+2.23%
US
BBH
+0.77%
© 2026 Longbridge｜Disclaimer